Page 7 - Ascletis Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ascletis pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ascletis Pharma Today - Breaking & Trending Today

Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned

/PRNewswire/ The enrollment of the 52-week Phase II clinical trial of thyroid hormone receptor β (THRβ) agonist ASC41 developed in house by Gannex Pharma Co.. ....

Hong Kong , Ssris Snris , Gannex Pharma Co Ltd , Hong Kong Stock Exchange , Ascletis Pharma Inc , Madrigal Pharmaceuticals Inc , Ascletis Pharma , Madrigal Pharmaceuticals , Resmetirom Phase , Once Daily Oral Dosing , Knot Head , Ascletis Pharma Inc ,

Ascletis gets Chinese drug regulator nod to start trial of oral COVID therapy

Ascletis Pharma (ASCLF) said China's National Medical Products Administration ((NMPA)) approved its investigational new drug ((IND)) application for starting a trial of oral drug ASC11. ....

Jinzi Wu , Pardes Bioscience , Ascletis Pharma , China National Medical Products Administration , National Medical Products Administration , Enanta Pharmaceutical , Ascletis Founder ,

Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne

To date, approximately 50% enrolled patients have completed 12-week treatment and all enrolled patients are expected to complete 12-week treatment by the end. ....

United States , Hong Kong , Leihong Xiang , Jinzij Wu , Physician Of Dermatological Department , Fudan University , Hong Kong Stock Exchange , Institute Of Dermatology , Drug Administration , Dermatology Division Of Chinese Medical Doctor Association , Ascletis Pharma Inc , Ascletis Pharma , Global Assessment , Chief Physician , Dermatological Department , Huashan Hospital , Executive Deputy Director , Deputy Director , Dermatology Division , Chinese Medical Doctor Association , Topical Clascoterone Cream , Patients With Facial Acne , Two Phase , North America , Ascletis Pharma Inc ,

Ascletis Announces IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19 Accepted by China NMPA

/PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the Investigational New Drug (IND) application of ASC11, an oral inhibitor. ....

Hong Kong , China National Medical Products Administration , Hong Kong Stock Exchange , Ascletis Pharma Inc , Ascletis Pharma , Investigational New Drug , Ascletis Pharma Inc ,

Ascletis Announces IND Approval of Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by U.S. FDA

/PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that the U.S. Food and Drug Administration (FDA) has approved the Investigational New. ....

Hong Kong , Illinois Institute Of Technology , United States , Jinzij Wu , National Institute Of Infectious Diseases , Research Institute , Hong Kong Stock Exchange , World Health Organization , Drug Administration , Ascletis Pharma Inc , Ascletis Pharma , Investigational New Drug , Illinois Institute , National Institute , Infectious Diseases , Ascletis Pharma Inc ,